Streetbeat News

Revenues

ICCM

IceCure Medical reports a 42% increase in ProSense® sales for 2024 in North America, indicating growing adoption of their cryoablation technology for breast tumors. An FDA decision on market authorization for early-stage breast cancer is anticipated in Q1 2025.

Portfolio Pulse from

January 13, 2025 | 12:15 pm

BSEM

BioStem Technologies reported a record preliminary fourth-quarter net revenue of $102.9 million and expects full-year 2024 net revenue to reach $301.8 million. The company focuses on placental-derived products for advanced wound care.

Portfolio Pulse from

January 13, 2025 | 12:15 pm

CTRN

Citi Trends, Inc. reported its holiday sales results for the quarter-to-date period ending January 4, 2025, with total sales of $174.4 million, up from $169.0 million in the same period in 2023.

Portfolio Pulse from

January 13, 2025 | 12:00 pm

INSP

Inspire Medical Systems, Inc. reported a 25% year-over-year revenue growth for Q4 2024 and a 28% growth for the full year 2024. The company also provided initial revenue guidance for 2025.

Portfolio Pulse from

January 13, 2025 | 12:00 pm

AAPL

Apple's iPhone sales in China fell by 5% due to stronger competition and the absence of AI features in the Chinese market, as reported by Bloomberg News.

Portfolio Pulse from

January 13, 2025 | 12:00 pm

JILL

J.Jill, Inc. has reaffirmed its guidance for the fourth quarter and full year 2024, expecting a 4% to 6% decrease in net sales compared to the previous year's 14-week fourth quarter, but a 1% to 3% increase in comparable sales for the 13-week period.

Portfolio Pulse from

January 13, 2025 | 12:00 pm

DOCS

Doximity has been upgraded to a buy rating due to a recent share price pullback, strong engagement metrics, and deeper client relationships. The company reported 20% year-over-year revenue growth in 2Q25, surpassing management's guidance. Increased user adoption and higher revenue per user, along with AI-driven tools and expanded Client Portal access, are enhancing its value proposition.

Portfolio Pulse from

January 13, 2025 | 12:00 pm

ANIP

ANI Pharmaceuticals has reaffirmed its financial guidance for 2024 and provided a preliminary outlook for 2025. The company's CEO will discuss these updates at the J.P. Morgan Healthcare Conference.

Portfolio Pulse from

January 13, 2025 | 12:00 pm

AS

Amer Sports Inc. announced preliminary financial results for fiscal year 2024, including revenue and adjusted operating margin, ahead of the ICR conference. Detailed results and 2025 guidance will be provided on February 25, 2025.

Portfolio Pulse from

January 13, 2025 | 12:00 pm

BA

AerCap's CEO has expressed concerns that potential new trade tariffs proposed by U.S. President-elect Donald Trump could disrupt supply chains and impact Boeing's cash recovery efforts.

Portfolio Pulse from

January 13, 2025 | 11:45 am